Lobato R, Martínez L, Leal N, Díaz M, Díez-Pascual R, Velasco B, Ros Z, López-Gutiérrez J C
Departamento de Cirugía Pediátrica, Hospital Infantil La Paz, Madrid.
Cir Pediatr. 1997 Jul;10(3):119-21.
In 1982, Mulliken and Glowacki classificated congenital vascular lesions in two biological groups with different treatment, evolution and prognosis: Haemangiomas and Vascular malformations. We have seen 230 patients, 145 with haemangiomas and 85 with vascular malformations (74 with low flow and 11 with high flow). We have reviewed clinical, evolutive and ecographic findings. Depending on the type and localization of the lesion, we completed the study with CT, MRI and angiography. Among all the patients with haemangiomas; 45 were treated with local or systemic steroids because of bleeding, ulceration or affection in functional areas. In two more, we used interferon alfa 2a because of Kassabach-Merritt Syndrome. 23 were operated on with good aesthetic results. Patients with vascular malformations were managed with embolization, sclerotherapy, surgical approach or conservatively. Capillary malformations were treated with lasertherapy. We emphasize in correct classification of vascular lesions prior to start diagnosis, treatment or parents information.
1982年,穆利肯和格沃茨基将先天性血管病变分为两个生物学组,它们具有不同的治疗方法、发展过程和预后:血管瘤和血管畸形。我们共诊治了230例患者,其中145例为血管瘤,85例为血管畸形(74例低流量型,11例高流量型)。我们回顾了临床、病情发展及超声检查结果。根据病变的类型和部位,我们还通过CT、MRI和血管造影完善了研究。在所有血管瘤患者中,45例因出血、溃疡或功能区受累而接受了局部或全身类固醇治疗。另外2例因卡萨巴赫-梅里特综合征使用了干扰素α 2a。23例接受了手术治疗,美容效果良好。血管畸形患者采用栓塞、硬化治疗、手术或保守治疗。毛细血管畸形采用激光治疗。我们强调在开始诊断、治疗或向家长说明情况之前,要对血管病变进行正确分类。